High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients
暂无分享,去创建一个
T. Yamanaka | K. Miyagawa | Yoko Yamamoto | S. Ishihara | Yuzo Nagai | E. Sunami | K. Hata | T. Nishikawa | Toshiaki Tanaka | T. Kiyomatsu | K. Kawai | H. Nozawa | Toshiaki Watanabe | J. Tanaka | S. Kazama | H. Yamaguchi | Takaaki Yasuhara
[1] K. Miyagawa,et al. Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength , 2014, Nature Communications.
[2] J. Tabernero,et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. , 2013, The New England journal of medicine.
[3] G. Sauter,et al. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma , 2013, International journal of cancer.
[4] Xiaolan Zhao,et al. Homologous recombination and its regulation , 2012, Nucleic acids research.
[5] W. Jia,et al. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma , 2011, Journal of surgical oncology.
[6] W. Heyer,et al. Functions of the Snf2/Swi2 family Rad54 motor protein in homologous recombination. , 2011, Biochimica et biophysica acta.
[7] M. Copetti,et al. High RAD51 mRNA expression characterize estrogen receptor‐positive/progesteron receptor‐negative breast cancer and is associated with patient's outcome , 2011, International journal of cancer.
[8] J. Barrett,et al. Patterns of Expression of DNA Repair Genes and Relapse From Melanoma , 2010, Clinical Cancer Research.
[9] T. Helleday. Homologous recombination in cancer development, treatment and development of drug resistance. , 2010, Carcinogenesis.
[10] Alan Cantor,et al. Rationally Designed Pharmacogenomic Treatment Using Concurrent Capecitabine and Radiotherapy for Glioblastoma; Gene Expression Profiles Associated with Outcome , 2010, Clinical Cancer Research.
[11] J. Welsh,et al. Rad51 protein expression and survival in patients with glioblastoma multiforme. , 2009, International journal of radiation oncology, biology, physics.
[12] K. Miyagawa,et al. Biochemical analysis of the N-terminal domain of human RAD54B , 2008, Nucleic acids research.
[13] Daniel J. Freeman,et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Joseph G Ibrahim,et al. UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. , 2007, Journal of the National Cancer Institute.
[15] L. Skoog,et al. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] Wolf-Dietrich Heyer,et al. Rad54: the Swiss Army knife of homologous recombination? , 2006, Nucleic acids research.
[17] R. Weichselbaum,et al. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. , 2006, International journal of oncology.
[18] S. Kato,et al. Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection , 2006, Clinical Cancer Research.
[19] W. Zhong,et al. High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients , 2005, British Journal of Cancer.
[20] R. Houlston,et al. Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] T. Helleday,et al. The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer , 2003, International journal of cancer.
[22] M. Murphy,et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential , 2003, Nature Genetics.
[23] L. Symington. Role of RAD52 Epistasis Group Genes in Homologous Recombination and Double-Strand Break Repair , 2002, Microbiology and Molecular Biology Reviews.
[24] K. Miyagawa,et al. Human Rad54B is a double-stranded DNA-dependent ATPase and has biochemical properties different from its structural homolog in yeast, Tid1/Rdh54. , 2002, Nucleic acids research.
[25] K. Miyagawa,et al. A role for RAD54B in homologous recombination in human cells , 2002, The EMBO journal.
[26] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[27] R. Fishel,et al. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. , 2001, Molecular cell.
[28] D. Schild,et al. Homologous recombinational repair of DNA ensures mammalian chromosome stability. , 2001, Mutation research.
[29] R. Fotedar,et al. The functions of the cdk-cyclin kinase inhibitor p21WAF1. , 2000, Pathologie-biologie.
[30] Hiroki Inui,et al. Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer , 1999, Oncogene.
[31] S. Vispé,et al. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. , 1998, Nucleic acids research.
[32] P. Baumann,et al. Synergistic actions of Rad51 and Rad52 in recombination and DNA repair , 1998, Nature.
[33] L. Cox. Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1 , 1997, The Journal of pathology.
[34] C. Pabo,et al. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. , 1993, Genes & development.
[35] J. Hardcastle,et al. Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.